Category : Seeking Alpha

Super League Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Update on Strategic Discussions to Accelerate Path to Profitability and Diversify Revenues

~ Ann Hand to Support Strategic Alternative Initiatives as Executive Chair; President Matt Edelman Promoted to the Role of Chief Executive Officer ~

Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

- Received U.S. Food and Drug Administration (FDA) approval of Symvess™ (acellular tissue engineered vessel-tyod) for the treatment of extremity vascular trauma -

Base Carbon Announces Investor Call

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with affiliates, “Base Carbon”, or the “Company”), is ple...

Fixing of coupon rates - Nykredit Realkredit A/S

To Nasdaq Copenhagen

Fastsættelse af kuponrenter - Nykredit Realkredit A/S

Til Nasdaq Copenhagen

Fastsættelse af kuponrenter (Senior, Non-Preferred Note)

DLR Kredit A/S

Flow Capital Announces $1.5 Million of Follow-On Investments to a Fintech Company

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV:FW) (“Flow Capital” or the “Company”), a leading provider of flexible growth capital and alternative debt solutions, announces $1.5 million of follow-on investments made over the...

Prospect Capital’s Credit Ratings Reaffirmed Investment Grade by Morningstar DBRS with Stable Trend

NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) ("Prospect", “our”, or “we”) today announced that Morningstar DBRS ("DBRS") has reaffirmed Prospect’s investment grade issuer and long term senior debt credi...

FDA Issues Complete Response Letter for Etripamil for PSVT

CRL focused on CMC; no clinical issues relating to etripamil raised

Aya Gold & Silver Reports Q4 and Full Year 2024 Results; Announces 2025 Production and Cost Guidance

MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced financial and operational results for the fourth quarter and full year ended December 31, 2024. All amount...

Aya Or & Argent annonce ses résultats pour le T4 et l’exercice 2024 et présente ses prévisions pour 2025 en termes de production et de coûts

MONTRÉAL, 28 mars 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a annoncé aujourd’hui ses résultats financiers et opérationnels pour le quatrième trimestre et l’exercice financier term...

FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology

SAN FRANCISCO, March 28, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the peer-reviewed publication titled “A Phase 1, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, i...